Genetic markers (p14ARF, p15INK4b, and p16INK4a) were variably elevated during prostate cancer progression, according to Zhang et al. The RAS‐association domain family, often known as RASSF, has been linked to the development of prostate cancer.143. Here, CDKN2A is linked to prostate carcinoma.